ArticleCureus2025
A Rare Case of Metaplastic Breast Carcinoma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metaplastic breast cancer (MBC) is a sporadic and highly aggressive form of breast cancer characterized histologically by a group of highly heterogeneous cells. Typical presentation is marked by a large palpable breast mass without lymph node involvement. MBC is a common cause of triple-negative breast cancer. In this case, we describe a 65-year-old woman who presented with a palpable breast mass and associated inflammatory breast changes. Following a thorough work-up with a breast ultrasound, bilateral breast magnetic resonance imaging (MRI), and an image-guided needle biopsy, the patient was found to have triple-negative MBC, with squamous differentiation. This case highlights the current treatment methods employed for MBC and displays the challenging therapeutic task encountered when managing this disease. This report aims to emphasize the relevance of this cancer type and to encourage further research toward the development of disease-specific treatment guidelines.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.